---
title: GLP-1 Medicines and Sudden Vision Loss
description: New GLP-1 safety warnings highlight a rare risk of sudden vision loss. Learn about NAION, the evidence and what patients and pharmacies should know.
image: https://weightlossforlife.com.au/hubfs/Sudden%20vision%20changes%20and%20eye%20health.jpg
---

[Skip to content](https://weightlossforlife.com.au/blog/glp-1-medicines-and-sudden-vision-loss#main-content)

[![circle company logo](https://weightlossforlife.com.au/hs-fs/hubfs/circle%20company%20logo.png?width=200&height=200&name=circle%20company%20logo.png)](https://weightlossforlife.com.au/)

- [Home](https://weightlossforlife.com.au)
- [About Us](https://weightlossforlife.com.au/about)
- [Blog](https://weightlossforlife.com.au/blog)
- [Contact Us](https://weightlossforlife.com.au/contact)
- [Ultra Lite](https://ultralite.com.au/)

Open main navigation

Close main navigation

- [Home](https://weightlossforlife.com.au)
- [About Us](https://weightlossforlife.com.au/about)
- [Blog](https://weightlossforlife.com.au/blog)
- [Contact Us](https://weightlossforlife.com.au/contact)
- [Ultra Lite](https://ultralite.com.au/)
- [Newsletters](mailto:malcolm@ultralite.com.au)
- <https://weightlossforlife.com.au/hs-search-results>

[Newsletters](mailto:malcolm@ultralite.com.au)

<https://weightlossforlife.com.au/hs-search-results>

[Health Professionals](https://weightlossforlife.com.au/blog/tag/health-professionals) [Health Benefits](https://weightlossforlife.com.au/blog/tag/health-benefits) [GPL-1 DRUGS](https://weightlossforlife.com.au/blog/tag/gpl-1-drugs) [Healthy Aging](https://weightlossforlife.com.au/blog/tag/healthy-aging)

# GLP-1 Medicines and Sudden Vision Loss

 Published by [Malcolm McLean Founder of The Ultra Lite Ketogenic Lifestyle Program](https://weightlossforlife.com.au/blog/author/malcolm-mclean-founder-of-the-ultra-lite-ketogenic-lifestyle-program) on Nov 16, 2026, 5:08:19 PM

![](https://weightlossforlife.com.au/hs-fs/hubfs/Sudden%20vision%20changes%20and%20eye%20health.jpg?width=1024&height=450&name=Sudden%20vision%20changes%20and%20eye%20health.jpg)

A sudden change in your sight can be painless and still be an emergency. On 9 November 2026, the US Food and Drug Administration required a new warning for GLP-1 medicines over a potential increase in a rare optic nerve disorder that can cause permanent vision loss. The requirement covers semaglutide medicines such as Ozempic and Wegovy, and tirzepatide medicines such as Mounjaro and Zepbound. \[1\]

| **Sudden vision loss needs immediate medical help**If sight suddenly dims, blurs or disappears in one eye, or part of your field of vision goes missing, get medical help immediately, even if there is no pain. If your doctor or optometrist is unavailable, go to an emergency department or call triple zero (000) in Australia. Tell the clinician which medicines you take. \[1, 2\] |
| --- |

## **What happens to the eye**

NAION stands for non-arteritic anterior ischaemic optic neuropathy. It occurs when blood flow to the front of the optic nerve is reduced. The result can be a sudden loss of part of the visual field or a more substantial loss of sight, usually in one eye. The TGA says no treatment has been shown to improve visual acuity outcomes in NAION. Urgent assessment still matters because other causes of sudden vision loss can require time-sensitive treatment. \[1–3\]

## **Australia had already acted**

On 23 July 2026, the TGA announced updated safety information across this medicine class, including semaglutide and tirzepatide. Australian semaglutide information advises urgent ophthalmological assessment for sudden vision loss and discontinuation if NAION is confirmed. In June 2025, the European Medicines Agency classified NAION as a very rare side effect of semaglutide. \[3, 4\]

# **How large is the risk**

The FDA reviewed 126 randomised controlled trials involving 134,253 participants and identified 15 probable cases of NAION. Ten occurred among GLP-1 users and five among comparator participants, all five on placebo. The pooled rate difference was 2.6 probable cases per 100,000 person-years. These figures combine different drugs and trial populations. With so few cases, they cannot give a reliable estimate for each brand or predict any individual’s risk. \[1\]

![](https://weightlossforlife.com.au/hs-fs/hubfs/image-png-Nov-16-2026-05-49-12-3604-AM.png?width=823&height=262&name=image-png-Nov-16-2026-05-49-12-3604-AM.png)

**Source: FDA pooled clinical trial analysis. Comparator groups received placebo or a non-GLP-1 glucose-lowering medicine. A person-year is one person followed for one year. \[1\]**

## **Why estimates differ across studies**

In the FDA’s separate analysis of US health records for adults with type 2 diabetes, GLP-1 use was associated with a higher rate of NAION than DPP-4 inhibitor use. The difference versus SGLT2 inhibitors was statistically inconclusive. The comparison drug, the patients studied and how researchers identified cases all affect the estimate. \[1\]

A Danish–Norwegian registry study found about 1.4 additional cases per 10,000 person-years among adults with type 2 diabetes starting semaglutide compared with those starting an SGLT2 inhibitor. A large international study found a smaller signal that varied by analysis. A US study that grouped semaglutide and tirzepatide together found 35 cases versus 19 with other diabetes medicines over two years. That combined result leaves tirzepatide’s individual risk uncertain. \[5–7\]

A 2026 review from US ophthalmology and neuro-ophthalmology specialists found that the relative risk with semaglutide may be about twice as high across pooled analyses, with a small absolute risk. The evidence is clearer for people with type 2 diabetes. Estimates for people using these medicines for weight loss without diabetes remain less certain. \[8\]

# **What patients and pharmacies can do**

## **Does endotoxin explain these cases**

The post that prompted this article attributes NAION cases to bacterial endotoxin. The linked article is a general list about endotoxin harms. Establishing that explanation for these cases would require evidence of exposure in affected patients and a credible link to their optic nerve injury. The FDA and TGA reviews do not establish that chain of evidence. Lawsuits raise allegations, and the clinical studies and regulator notices are the basis for the warning described here. \[1, 3, 9, 10\]

## **Make the warning part of every conversation**

Patients who feel well can ask their prescriber to review the warning in light of why they take the medicine, their medical history and any previous NAION. If you have no new vision symptoms, speak with your prescriber before changing or stopping treatment. If symptoms appear suddenly, seek immediate care. Once a diagnosis is confirmed, the treating team can decide how to manage the medicine and any underlying diabetes or other conditions. \[1–4\]

I would like every pharmacy and prescribing service to say this in plain language at the first supply and remind patients at follow-up: sudden loss of sight, even in just one eye and even without pain, needs immediate medical assessment. People should hear that advice before they need it.

## **Sources**

1\. [FDA drug safety communication and pooled trial analysis, 9 November 2026](https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential)

2\. [Healthdirect Australia guidance on sudden vision loss](https://www.healthdirect.gov.au/conditions/eye-diseases/blindness)

3\. [TGA safety update on GLP-1 medicines and NAION, 23 July 2026](https://www.tga.gov.au/news/safety-updates/glp-1-ras-and-rare-vision-disorder)

4\. [European Medicines Agency review of semaglutide and NAION, June 2025](https://www.ema.europa.eu/en/news/prac-concludes-eye-condition-naion-very-rare-side-effect-semaglutide-medicines-ozempic-rybelsus-wegovy)

5\. [Simonsen et al. Danish–Norwegian registry study, 2025](https://doi.org/10.1111/dom.16316)

6\. [OHDSI international study in JAMA Ophthalmology, 2025](https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2830475)

7\. [JAMA Network Open study of semaglutide or tirzepatide, 2025](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2837377)

8\. [AAO and NANOS consensus statement, 2026](https://www.aao.org/Assets/f1be6b78-af02-4faf-b49c-cb94f8efacf1/639143694552330000/glp-1-ras-and-the-risk-of-naion-2026)

9\. [Geoff Pain’s linked endotoxin list, 2023](https://geoffpain.substack.com/p/endotoxin-harms-list-l-z)

10\. [The Wall Street Journal reporting on US lawsuits, September 2026](https://www.wsj.com/health/pharma/patients-sue-glp-1-drugmakers-over-risk-of-sudden-vision-loss-f60d7acb)

###### Related News Articles

[![Why UltraLite Offers Pharmacy a More Sustainable Weight-Management Future](https://weightlossforlife.com.au/hs-fs/hubfs/health%20practitioner%20and%20healthy%20lifestyle.jpg?width=624&height=427&name=health%20practitioner%20and%20healthy%20lifestyle.jpg)](https://weightlossforlife.com.au/blog/beyond-the-prescription-why-ultralite-offers-pharmacy-a-more-sustainable-weight-management-future-1)

[Health Professionals](https://weightlossforlife.com.au/blog/tag/health-professionals), [Health Practitioners](https://weightlossforlife.com.au/blog/tag/health-practitioners), [GPL-1 DRUGS](https://weightlossforlife.com.au/blog/tag/gpl-1-drugs)

#### [Beyond the Prescription: Why UltraLite Offers Pharmacy a More Sustainable Weight-Management Future](https://weightlossforlife.com.au/blog/beyond-the-prescription-why-ultralite-offers-pharmacy-a-more-sustainable-weight-management-future-1)

**A practical, financially viable pathway that teaches customers how to manage their health for life**

[![](https://weightlossforlife.com.au/hs-fs/hubfs/understanding%20pharmacy.jpg?width=624&height=427&name=understanding%20pharmacy.jpg)](https://weightlossforlife.com.au/blog/a-fee-for-service-model-for-pharmacy-weight-management)

[Health Professionals](https://weightlossforlife.com.au/blog/tag/health-professionals), [Health and Weight Loss Program](https://weightlossforlife.com.au/blog/tag/health-and-weight-loss-program), [Health Practitioners](https://weightlossforlife.com.au/blog/tag/health-practitioners), [GPL-1 DRUGS](https://weightlossforlife.com.au/blog/tag/gpl-1-drugs)

#### [A Fee for Service Model for Pharmacy Weight Management](https://weightlossforlife.com.au/blog/a-fee-for-service-model-for-pharmacy-weight-management)

A patient collects their first GLP-1 prescription. They know how to take it, but they still have to...

[![](https://weightlossforlife.com.au/hs-fs/hubfs/health%20journey.jpg?width=624&height=427&name=health%20journey.jpg)](https://weightlossforlife.com.au/blog/beyond-the-prescription-why-ultralite-offers-pharmacy-a-more-sustainable-weight-management-future)

[Health and Weight Loss Program](https://weightlossforlife.com.au/blog/tag/health-and-weight-loss-program), [Health Practitioners](https://weightlossforlife.com.au/blog/tag/health-practitioners), [GPL-1 DRUGS](https://weightlossforlife.com.au/blog/tag/gpl-1-drugs), [Healthy Aging](https://weightlossforlife.com.au/blog/tag/healthy-aging)

#### [We Don't Have a Medication Shortage. We Have a Health-Creation Shortage.](https://weightlossforlife.com.au/blog/beyond-the-prescription-why-ultralite-offers-pharmacy-a-more-sustainable-weight-management-future)

Australia is not suffering because we lack pharmacies.

[![Ozempic and Pregnancy](https://weightlossforlife.com.au/hs-fs/hubfs/PREGNANCY%20FEATURE.jpg?width=624&height=427&name=PREGNANCY%20FEATURE.jpg)](https://weightlossforlife.com.au/blog/ozempic-and-pregnancy-the-warning-every-woman-deserves-to-hear)

[Health Professionals](https://weightlossforlife.com.au/blog/tag/health-professionals), [GPL-1 DRUGS](https://weightlossforlife.com.au/blog/tag/gpl-1-drugs), [Long-term weight management](https://weightlossforlife.com.au/blog/tag/long-term-weight-management)

#### [Ozempic and Pregnancy: The Warning Every Woman Deserves to Hear](https://weightlossforlife.com.au/blog/ozempic-and-pregnancy-the-warning-every-woman-deserves-to-hear)

*What women need to know about GLP-1 medications, pregnancy planning and contraception*

[![circle company logo (2)](https://weightlossforlife.com.au/hs-fs/hubfs/circle%20company%20logo%20(2).png?width=200&height=200&name=circle%20company%20logo%20(2).png "circle company logo (2)")](https://22037879.hs-sites.com/aspect/)

Live life at the full potential.

#### Weight Loss for life

- [About](https://weightlossforlife.com.au/about)
- [Top Articles](https://weightlossforlife.com.au/blog)
- [Ultralite](https://ultralite.com.au/)

#### Privacy and Policy

- [Privacy and Policy](https://weightlossforlife.com.au/privacy-and-policy)

##### Disclaimer:

 The information on this website is provided solely for informational purposes and should not be construed as professional medical or health advice. The information provided here is based on personal experiences, research, and general health and wellness knowledge. Before making any changes to your diet, exercise routine, or lifestyle, it is always best to consult with a qualified healthcare professional. This website's authors and contributors are not liable for any consequences or damages resulting from the use or misuse of the information provided. You acknowledge and agree to accept full responsibility for your own health decisions by accessing and using this website.

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Malcolm McLean Founder of The Ultra Lite Ketogenic Lifestyle Program",
    "url" : "https://weightlossforlife.com.au/blog/author/malcolm-mclean-founder-of-the-ultra-lite-ketogenic-lifestyle-program"
  },
  "dateModified" : "2026-11-16T06:08:19.670Z",
  "datePublished" : "2026-11-16T06:08:19.000Z",
  "headline" : "GLP-1 Medicines and Sudden Vision Loss",
  "image" : [ "https://weightlossforlife.com.au/hubfs/Sudden%20vision%20changes%20and%20eye%20health.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://weightlossforlife.com.au/blog/glp-1-medicines-and-sudden-vision-loss",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://weightlossforlife.com.au/hubfs/circle%20company%20logo-May-22-2023-07-42-43-8201-AM.png"
    },
    "name" : "Weight Loss For Life"
  }
}
```